Cargando…
Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler
Inducing mitochondrial uncoupling (mUncoupling) is an attractive therapeutic strategy for treating metabolic diseases because it leads to calorie-wasting by reducing the efficiency of oxidative phosphorylation (OXPHOS) in mitochondria. Here we report a safe mUncoupler, OPC-163493, which has unique p...
Autores principales: | Kanemoto, Naohide, Okamoto, Takashi, Tanabe, Koji, Shimada, Takahiro, Minoshima, Hitomi, Hidoh, Yuya, Aoyama, Masashi, Ban, Takashi, Kobayashi, Yusuke, Ando, Hikaru, Inoue, Yuki, Itotani, Motohiro, Sato, Seiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520346/ https://www.ncbi.nlm.nih.gov/pubmed/31092829 http://dx.doi.org/10.1038/s41467-019-09911-6 |
Ejemplares similares
-
New Approach to Drug Discovery of a Safe Mitochondrial
Uncoupler: OPC-163493
por: Okamoto, Takashi, et al.
Publicado: (2021) -
Preclinical safety profile of a liver-localized mitochondrial uncoupler: OPC-163493
por: Inoue, Yuki, et al.
Publicado: (2022) -
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
por: Lu, Qingguo, et al.
Publicado: (2019) -
New Antidiabetes Agent Targeting Both Mitochondrial Uncoupling and Pyruvate Catabolism: Two Birds With One Stone
por: Rui, Liangyou
Publicado: (2019) -
Beneficial Metabolic Effects of TREM2 in Obesity Are Uncoupled From Its Expression on Macrophages
por: Sharif, Omar, et al.
Publicado: (2021)